Dr. Raphael Schiffmann, MD, MHSc, FAAN

Clinical Trials

• Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged 12 to <18 Years)
• Study of the Safety, Efficacy, & PK of Pegunigalsidase Alfa (PRX-102) 2 mg/kg IV Administered Every 4 Weeks in Fabry Disease Patients
• Natural History of the Leukodystrophies
• Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function
• The Natural History of Mucolipidosis Type IV

Media Releases

Get to know Neurologist Dr. Raphael Schiffmann, who serves patients in Dallas, Texas.

Dr. Schiffmann is a neurologist who specializes in solving diagnostic puzzles concerning neurological disorders of unknown cause. He understands the frustration and discouragement caused by living with an undiagnosed disease or condition and applies knowledge acquired during 25 plus years of experience in the field of neurology to try and assist his patients.  

Dr. Schiffmann is currently serving patients at Baylor Scott & White Neurometabolic & Undiagnosed Neurological Diseases – a clinic that specializes in diagnosing rare or difficult-to-diagnose neurological conditions in both children and adults. These undiagnosed diseases may include lysosomal storage diseases and leukodystrophies, as well as other genetic diseases that affect the nervous system.

Dr. Schiffmann received his medical degree from the State University of Liege in Belgium. Thereafter, he went on to complete an internship at the Liege University Hospital in Liege, Belgium, followed by a residency in pediatrics at the Shaare Zedek Medical Center in Jerusalem, Israel. He also completed fellowship trainings in pediatric neurology at Boston City Hospital and Tufts New England Medical Center, as well as in neurometabolic diseases at the National Institute of Neurological Disorders and Stroke (NINDS) Developmental and Metabolic Neurology Branch. Furthermore, Dr. Schiffmann received his Master of Health Science in Clinical Research from Duke University in Durham, North Carolina.

Dr. Schiffmann holds professional memberships with several organizations, including the American Neurological Association, the Child Neurology Society (USA), the American Academy of Neurology (Fellow), the American Society of Human Genetics, and the Society for the Study of Inborn Errors of Metabolism (SSIEM).

Dr. Schiffmann is board-certified in neurology (with special qualification in child neurology) by the American Board of Psychiatry and Neurology (ABPN). The ABPN is a not-for-profit corporation dedicated to serving the public interest and the professions of psychiatry and neurology by promoting excellence in practice through certification and maintenance of certification processes.

Neurology is a branch of medicine dealing with disorders of the nervous system. As a neurologist, Dr. Schiffmann deals with the diagnosis and treatment of many categories of conditions and disease involving the central and peripheral nervous systems. His interests include the mechanism and treatment of neurometabolic genetic diseases such as lysosomal storage disorders, leukodystrophies and other neurogenetic disorders. He is also a leader in the study and treatment of many neurological disorders, including Fabry disease and Gaucher disease using enzyme replacement therapy, pharmacological chaperone and substrate reduction therapy.  

In addition to English, Dr. Schiffmann speaks Hebrew and French.

Recommended Articles

• Deep Brain Stimulation Surgery Improves Quality of Life for Parkinson's Patient

  Parkinson’s Disease Disrupts the Life of a Single DadMuscle spasms, stiffness, and decreased motor skills are not symptoms commonly associated with younger people in their 20s and 30s. For Bill Swayze, however, these symptoms appeared and resulted in early diagnosis of Parkinson’s at the rare...

• One Step Closer to a Cure: New Developments in Parkinson’s Research

  Parkinson's disease is a neurodegenerative disease that affects a lot of people worldwide with an estimated figure of about 1 million in the United States alone, according to the National Parkinson’s Foundation. Despite the sheer amount of support available for patients as seen in the dozens of...

• Parkinson's Debate: Should Patients Really Be Considered Sick?

  ‘Sick’ is a word that gets tossed around fairly often when referring to people who are suffering from different types of disease, and while this word might be fitting for those that have come down with some sort of passing condition (flu, chicken pox, etc.), it might not be very appropriate when...

• The Color Red Can Boost Your Energy

  According to a new study, seeing the color red may help to move the muscles faster and stronger with more force. This new finding may have applications in sports and other activities where a quick boost of energy is required.According to researcher Andrew Elliot, professor of psychology at the...

• How to Handle Talking About MS with Family

  Talking to loved ones about any chronic illness can be difficult, yet it’s an important conversation to have with individuals who will continue to be a part of your life’s journey. Opening dialogue creates the space for both you and your family to gain clarity and to establish trust and...

• Breakthrough Research on Facioscapulohumeral Muscular Dystrophy

  A study which was recently published in the Natural Communications journal, outlines a major breakthrough in research around facioscapulohumeral muscular dystrophy, also known as FSHD.The study was performed by the University of Minnesota Medical School. Researchers at the university inserted the...